Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Why don’t humans have hair all over their bodies? A biologist explains our lack of fur31.12.2025 - 2What to know about King Charles III's cancer treatment and his message to the public13.12.2025
- 3Illumina unveils dataset to speed up AI-powered drug discovery13.01.2026
- 4Shah Capital pushes for Novavax sale, warns of proxy fight12.11.2025
- 5The most effective method to Begin Your Excursion in Gold Venture19.10.2023
- Stop the ‘good’ vs ‘bad’ snap judgments and watch your world become more interesting
- Why Cannes Is the Ultimate New Year’s Eve Destination in the South of France’s Off-Season
- Alice Wong, founder of the Disability Visibility Project, dies at 51
- Don’t let food poisoning crash your Thanksgiving dinner
- Norovirus infections increase significantly, with positive test rates reaching 14%
- What to know about new CDC deputy director who has been critical of COVID vaccines
- Paraplegic engineer becomes the first wheelchair user to blast into space
- Land Rover Just Unveiled Its Dakar Rally Defender
- A Manual for Nations with Extraordinary Food
